Skip to main content
Top
Published in: Clinical Rheumatology 3/2016

01-03-2016 | Original Article

Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis

Authors: Yanmei Cheng, Aimin Dang, Naqiang Lv, Qian Gao, Bingwei Chen, Guozhang Liu

Published in: Clinical Rheumatology | Issue 3/2016

Login to get access

Abstract

Takayasu arteritis (TA) patients with active disease often have elevated serum C-reactive protein (CRP) levels, which usually decline with the disease remission. The serum CRP concentration has been showed to be related to CRP gene polymorphisms in previous studies. The present study aims to investigate the associations of serum level of CRP and CRP polymorphisms with TA. A total of 178 unrelated Chinese Han TA patients and 229 unrelated Chinese Han individuals without documented disease were enrolled in our studies. After a systemic search in the HapMap database, four single-nucleotide polymorphisms (SNPs) were selected, namely, rs1800947, rs3093077, rs1205, and rs2808630. The ligase detection reaction (LDR) was used in genotyping. CRP concentrations were determined using turbidimetric immunoassay. Genotype frequencies and allele frequencies of CRP variations were similar between TA patients and controls. CRP haplotype frequencies in patients were not significantly different from those of controls. No significant association between serum CRP concentrations and genotypes was found. Moreover, no association was found in CRP concentration between patients with types I, II, and III TA or between patients with or without pulmonary involvement. By contrast, serum CRP concentration was directly correlated with disease severity. In conclusion, CRP polymorphisms were not associated with TA susceptibility or serum CRP levels in the Chinese Han population. However, higher CRP level was correlated with a more serious disease status, which implies that CRP possibly contributes to the progression of TA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hirsch MS, Aikat BK, Basu AK (1964) Takayasu’s arteritis. Report of five cases with immunologic studies. Bull Johns Hopkins Hosp 115:29–64PubMed Hirsch MS, Aikat BK, Basu AK (1964) Takayasu’s arteritis. Report of five cases with immunologic studies. Bull Johns Hopkins Hosp 115:29–64PubMed
2.
go back to reference Numano F, Isohisa I, Kishi U et al (1978) Takayasu’s disease in twin sisters. Possible genetic factors. Circulation 58:173–177CrossRefPubMed Numano F, Isohisa I, Kishi U et al (1978) Takayasu’s disease in twin sisters. Possible genetic factors. Circulation 58:173–177CrossRefPubMed
3.
go back to reference Yoshida M, Kimura A, Katsuragi K et al (1993) DNA typing of HLA-B gene in Takayasu's arteritis. Tissue Antigens 42:87–90CrossRefPubMed Yoshida M, Kimura A, Katsuragi K et al (1993) DNA typing of HLA-B gene in Takayasu's arteritis. Tissue Antigens 42:87–90CrossRefPubMed
4.
go back to reference Isohisa I, Numano F, Maezawa H et al (1978) HLA-Bw52 in Takayasu disease. Tissue Antigens 12:246–248CrossRefPubMed Isohisa I, Numano F, Maezawa H et al (1978) HLA-Bw52 in Takayasu disease. Tissue Antigens 12:246–248CrossRefPubMed
5.
go back to reference Lv N, Dang A, Wang Z et al (2011) Association of susceptibility to Takayasu arteritis in Chinese Han patients with HLA-DPB1. Hum Immunol 72:893-896 Lv N, Dang A, Wang Z et al (2011) Association of susceptibility to Takayasu arteritis in Chinese Han patients with HLA-DPB1. Hum Immunol 72:893-896
6.
go back to reference Dang A, Wang B, Zhang Y et al (2002) Association of the HLA-DRB1 gene with susceptibility to aortoarteritis in a Chinese Han population. Hypertens Res 25:631–634CrossRefPubMed Dang A, Wang B, Zhang Y et al (2002) Association of the HLA-DRB1 gene with susceptibility to aortoarteritis in a Chinese Han population. Hypertens Res 25:631–634CrossRefPubMed
7.
go back to reference Firooz N, Albert DA, Wallace DJ et al (2011) High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 20:588-597 Firooz N, Albert DA, Wallace DJ et al (2011) High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 20:588-597
8.
go back to reference Hansen TK, Forsblom C, Saraheimo M et al (2010) Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia 53:1517-1524 Hansen TK, Forsblom C, Saraheimo M et al (2010) Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia 53:1517-1524
9.
go back to reference Galarraga B, Khan F, Kumar P et al (2008) C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford) 47:1780–1784CrossRef Galarraga B, Khan F, Kumar P et al (2008) C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford) 47:1780–1784CrossRef
10.
go back to reference Elliott P, Chambers JC, Zhang W et al (2009) Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302:37–48CrossRefPubMedPubMedCentral Elliott P, Chambers JC, Zhang W et al (2009) Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302:37–48CrossRefPubMedPubMedCentral
11.
go back to reference Reiner AP, Barber MJ, Guan Y et al (2008) Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet 82:1193–1201CrossRefPubMedPubMedCentral Reiner AP, Barber MJ, Guan Y et al (2008) Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. Am J Hum Genet 82:1193–1201CrossRefPubMedPubMedCentral
12.
go back to reference Ridker PM, Pare G, Parker A et al (2008) Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 82:1185–1192CrossRefPubMedPubMedCentral Ridker PM, Pare G, Parker A et al (2008) Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 82:1185–1192CrossRefPubMedPubMedCentral
13.
go back to reference Okada Y, Takahashi A, Ohmiya H et al (2011) Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus. Hum Mol Genet 20:1224-1231 Okada Y, Takahashi A, Ohmiya H et al (2011) Genome-wide association study for C-reactive protein levels identified pleiotropic associations in the IL6 locus. Hum Mol Genet 20:1224-1231
14.
go back to reference Palomino-Morales R, Vazquez-Rodriguez TR, Miranda-Filloy JA et al (2009) C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain. J Rheumatol 36:341–346PubMed Palomino-Morales R, Vazquez-Rodriguez TR, Miranda-Filloy JA et al (2009) C-reactive protein gene polymorphisms in biopsy-proven giant cell arteritis from Northwestern Spain. J Rheumatol 36:341–346PubMed
15.
go back to reference Kim HA, Chun HY, Kim SH et al (2009) C-reactive protein gene polymorphisms in disease susceptibility and clinical manifestations of Korean systemic lupus erythematosus. J Rheumatol 36:2238–2243CrossRefPubMed Kim HA, Chun HY, Kim SH et al (2009) C-reactive protein gene polymorphisms in disease susceptibility and clinical manifestations of Korean systemic lupus erythematosus. J Rheumatol 36:2238–2243CrossRefPubMed
16.
go back to reference Shih PB, Manzi S, Shaw P et al (2008) Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations. J Rheumatol 35:2171–2178CrossRefPubMedPubMedCentral Shih PB, Manzi S, Shaw P et al (2008) Genetic variation in C-reactive protein (CRP) gene may be associated with risk of systemic lupus erythematosus and CRP concentrations. J Rheumatol 35:2171–2178CrossRefPubMedPubMedCentral
17.
go back to reference Edberg JC, Wu J, Langefeld CD et al (2008) Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 17:1147–1155CrossRefPubMed Edberg JC, Wu J, Langefeld CD et al (2008) Genetic variation in the CRP promoter: association with systemic lupus erythematosus. Hum Mol Genet 17:1147–1155CrossRefPubMed
18.
go back to reference Rhodes B, Merriman ME, Harrison A et al (2010) A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med 7:e1000341 Rhodes B, Merriman ME, Harrison A et al (2010) A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med 7:e1000341
19.
go back to reference Webb M, Chambers A, AL-N A et al (2004) The role of 18 F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31:627–634CrossRefPubMed Webb M, Chambers A, AL-N A et al (2004) The role of 18 F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31:627–634CrossRefPubMed
20.
go back to reference Seitz M, Reichenbach S, Bonel HM et al (2011) Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly 141:w13156 Seitz M, Reichenbach S, Bonel HM et al (2011) Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly 141:w13156
21.
go back to reference Arend WP, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134CrossRefPubMed Arend WP, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129–1134CrossRefPubMed
22.
go back to reference Ishikawa K (1978) Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation 57:27–35CrossRefPubMed Ishikawa K (1978) Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation 57:27–35CrossRefPubMed
23.
go back to reference Ueno A, Awane Y, Wakabayashi A et al (1967) Successfully operated obliterative brachiocephalic arteritis (Takayasu) associated with the elongated coarctation. Jpn Heart J 8:538–544CrossRefPubMed Ueno A, Awane Y, Wakabayashi A et al (1967) Successfully operated obliterative brachiocephalic arteritis (Takayasu) associated with the elongated coarctation. Jpn Heart J 8:538–544CrossRefPubMed
25.
go back to reference Doumatey AP, Chen G, Tekola Ayele F et al (2012) C-reactive protein (CRP) promoter polymorphisms influence circulating CRP levels in a genome-wide association study of African Americans. Hum Mol Genet 21:3063-3072 Doumatey AP, Chen G, Tekola Ayele F et al (2012) C-reactive protein (CRP) promoter polymorphisms influence circulating CRP levels in a genome-wide association study of African Americans. Hum Mol Genet 21:3063-3072
26.
go back to reference Naitza S, Porcu E, Steri M et al (2012) A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet 8:e1002480 Naitza S, Porcu E, Steri M et al (2012) A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation. PLoS Genet 8:e1002480
27.
go back to reference Dehghan A, Dupuis J, Barbalic M et al (2011) Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123:731-738 Dehghan A, Dupuis J, Barbalic M et al (2011) Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123:731-738
28.
go back to reference Almeida OP, Norman PE, Allcock R et al (2009) Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol 38:1049–1059CrossRefPubMedPubMedCentral Almeida OP, Norman PE, Allcock R et al (2009) Polymorphisms of the CRP gene inhibit inflammatory response and increase susceptibility to depression: the Health in Men Study. Int J Epidemiol 38:1049–1059CrossRefPubMedPubMedCentral
29.
go back to reference Kardys I, de Maat MP, Uitterlinden AG et al (2006) C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J 27:1331–1337CrossRefPubMed Kardys I, de Maat MP, Uitterlinden AG et al (2006) C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J 27:1331–1337CrossRefPubMed
30.
go back to reference Miller DT, Zee RY, Suk Danik J et al (2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69:623–638CrossRefPubMed Miller DT, Zee RY, Suk Danik J et al (2005) Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69:623–638CrossRefPubMed
31.
go back to reference Komurcu-Bayrak E, Erginel-Unaltuna N, Onat A et al (2009) Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. Atherosclerosis 206:474–479CrossRefPubMed Komurcu-Bayrak E, Erginel-Unaltuna N, Onat A et al (2009) Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults. Atherosclerosis 206:474–479CrossRefPubMed
32.
go back to reference Polterauer S, Grimm C, Zeillinger R et al (2011) Association of C-reactive protein (CRP) gene polymorphisms, serum CRP levels and cervical cancer prognosis. Anticancer Res 31:2259-2264 Polterauer S, Grimm C, Zeillinger R et al (2011) Association of C-reactive protein (CRP) gene polymorphisms, serum CRP levels and cervical cancer prognosis. Anticancer Res 31:2259-2264
33.
go back to reference Veen G, Giltay EJ, van Vliet IM et al (2011) C-reactive protein polymorphisms are associated with the cortisol awakening response in basal conditions in human subjects. Stress 14:128-135 Veen G, Giltay EJ, van Vliet IM et al (2011) C-reactive protein polymorphisms are associated with the cortisol awakening response in basal conditions in human subjects. Stress 14:128-135
34.
go back to reference Ottaviani S, Gorrini M, Scabini R et al (2011) C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. Transl Res 157:332-338 Ottaviani S, Gorrini M, Scabini R et al (2011) C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. Transl Res 157:332-338
35.
go back to reference Walter MA, Melzer RA, Schindler C et al (2005) The value of [18 F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32:674–681CrossRefPubMed Walter MA, Melzer RA, Schindler C et al (2005) The value of [18 F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 32:674–681CrossRefPubMed
36.
go back to reference Jiang L, Li D, Yan F et al (2012) Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Int J Cardiol 155:262-267 Jiang L, Li D, Yan F et al (2012) Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Int J Cardiol 155:262-267
Metadata
Title
Serum C-reactive protein level but not its gene polymorphism is associated with Takayasu arteritis
Authors
Yanmei Cheng
Aimin Dang
Naqiang Lv
Qian Gao
Bingwei Chen
Guozhang Liu
Publication date
01-03-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 3/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2674-3

Other articles of this Issue 3/2016

Clinical Rheumatology 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.